| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Dorso.ventral axis formation |
3 genes: ETS2, NOTCH2, MAPK1
|
0.004971 |
| mTOR signaling pathway |
4 genes: RICTOR, MAPK1, RPS6KA3, RPS6KB1
|
0.006009 |
| Inositol phosphate metabolism |
4 genes: PIK3C2A, PI4K2A, IPPK, SYNJ1
|
0.008304 |
| Axon guidance |
6 genes: EFNA1, EFNB2, ARHGEF12, GNAI1, MAPK1, SEMA4A
|
0.01004 |
| Oocyte meiosis |
5 genes: PPP1CB, PPP2R5A, MAPK1, RPS6KA3, SMC1A
|
0.02217 |
| Phosphatidylinositol signaling system |
4 genes: PIK3C2A, PI4K2A, IPPK, SYNJ1
|
0.02391 |
| PI3K AKT signaling pathway |
10 genes: EFNA1, MAPK1, LAMB3, GNB1, RPS6KB1, PKN2, PPP2R2A, PPP2R5A, CDKN1B, CDK6
|
0.02666 |
| mRNA surveillance pathway |
4 genes: PPP2R2A, PPP2R5A, NXT2, RNMT
|
0.0292 |
| Protein processing in endoplasmic reticulum |
6 genes: UBQLN2, EIF2AK2, SSR1, UBE2D1, UBE2G1, EDEM1
|
0.03117 |
| Progesterone.mediated oocyte maturation |
4 genes: GNAI1, MAPK1, RPS6KA3, CCNA2
|
0.03389 |
| Tight junction |
5 genes: AMOTL1, GNAI1, PPP2R2A, ACTN1, TJP2
|
0.03934 |
| Fc gamma R.mediated phagocytosis |
4 genes: ARF6, MAPK1, RPS6KB1, WASL
|
0.04452 |
| Ubiquitin mediated proteolysis |
5 genes: BIRC6, UBE2D1, UBE2G1, UBE2H, UBE2Q2
|
0.04607 |